The Latin words “alma mater” means “nourishing or bountiful mother.” It is generally used in reverence to the nourishing qualities of institutions of learning. Without these wonderful institutions, celebrities like Mikhail Blagosklonny may never be known. We often lose sight of this fact and restrict our praise to the individuals. These institutions deserve encomiums including their teaching and non-teaching staff. Our focus for now will be on the prestigious First Pavlov State Medical University of St. Peterburg that gave the world a priceless asset in the person of Mikhail Blagosklonny. Visit ResearchGate to keep up to date with Mikhail’s latest work.
The bulk of Mikhail Blagosklonny’s knoweledge arguably came from his alma mater. If available records serve us right, then it is absolutely correct to say that he had no medical training in any other University aside First Pavlov State Medical University of St. Peterburg. His MD in Internal Medicine and Ph.D. in Experimental Medicine and Cardiology came from this same institution of learning. If truly Mikhail Blagosklonny has been a blessing to the world, then we should reserve some praise for First Pavlov State Medical University of St. Peterburg.
Mikhail Blagosklonny is one of the few global authorities on issues concerning cancer and aging. Before becoming a Professor of Oncology at the Roswell Park Cancer Institute, he spent quality time working at New York Medical College and Ordway Research Institute. All three institutions are globally recognized as a force to reckon with when it comes to the treatment of cancer and aging.
Here is a man overwhelmed with discovering new and effective targeted cancer therapies and underlying mechanisms of aging. His numerous researches aim at protecting normal cells from hazardous and damaging elements as well as coming up with efficient anti-aging drugs.
Blagosklonny’s theory on TOR signaling has been of tremendous help in the war against cancer and aging. He is about the strongest voice in support of rapamycin as a viable treatment option for cancer and aging. Rapamycin is widely known to slow tumor growth, so Blagosklonny believes that this attribute can also be utilized in retarding the aging process. Check Mikhail’s profile in LinkedIn
It is obvious that any write-up about the outstanding exploits of Mikhail Blagosklonny will not be complete without a mention of his alma mater. The later deserves some accolades as well.